Silvec Biologics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Silvec Biologics's estimated annual revenue is currently $2.5M per year.(i)
  • Silvec Biologics's estimated revenue per employee is $155,000

Employee Data

  • Silvec Biologics has 16 Employees.(i)
  • Silvec Biologics grew their employee count by 7% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M2-60%N/AN/A
#2
$2.9M38-31%$17.5MN/A
#3
$2.9M38-33%$10.5MN/A
#4
$19.8M1280%$69.4MN/A
#5
$9.6M62-15%N/AN/A
#6
$1.4M90%N/AN/A
#7
$2.5M160%N/AN/A
#8
$7.4M480%N/AN/A
#9
$0.2M1-83%N/AN/A
#10
$1.7M1122%N/AN/A
Add Company

What Is Silvec Biologics?

Silvec has discovered a new type of RNA that can be used to deliver beneficial traits to trees, vines, and bushes, without impacting their genomes. Its proprietary products can be applied via a single graft taking minutes to perform in seedlings or mature trees that induce them to produce their own anti-pathogenic or trait enhancing agents for the remainder of their lives. It does not damage them in any way, is not heritable, and does not spread from tree-to-tree. In January 2020, we successfully inoculated the first plant in history against a deadly disease. We believe this represents a comparable breakthrough for trees as the invention of vaccines and antibiotics have had for humans.

keywords:N/A

N/A

Total Funding

16

Number of Employees

$2.5M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.5M16-11%$64M
#2
$2.5M160%N/A
#3
$1M1614%N/A
#4
$2.5M1633%N/A
#5
$1.5M170%N/A